ArticleTrials2025
Optimizing bevacizumab dosing in first-line ovarian cancer treatment: the PGOG-ov1 trial.
Marta Ostrowska-Leśko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleTrials2025
Marta Ostrowska-Leśko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.